What is Artificial Labs?
Artificial Labs operates at the intersection of artificial intelligence and specialty insurance, providing a sophisticated platform designed to modernize placement and underwriting workflows. The company's technology connects disparate market participants, streamlines complex operational processes, and enhances data quality. By enabling insurance professionals to focus on higher-value risk decisions and client relationships, Artificial Labs aims to drive efficiency and innovation within the specialty coverage market.
How much funding has Artificial Labs raised?
Artificial Labs has raised a total of $55.3M across 3 funding rounds:
Angel/Seed
$5.3M
Series A
$5.1M
Series B
$45M
Angel/Seed (2019): $5.3M with participation from Force Over Mass Capital
Series A (2024): $5.1M led by Force Over Mass Capital, Augmentum Fintech, and Ms&ad Ventures
Series B (2026): $45M supported by TrueSight Ventures, 6 Degrees Capital, Augmentum Fintech, CommerzVentures, Move Capital, and Force Over Mass Capital
Key Investors in Artificial Labs
TrueSight Ventures
TrueSight Ventures is a venture capital firm focused on seed and early-stage investments in Europe, specializing in partnering with founders and providing strategic business advice and industry contacts.
6 Degrees Capital
6 Degrees Capital is an investment firm providing capital from Seed to Series B stages, with a specialization in Fintech, Enterprise Software, and Artificial Intelligence, offering strategic direction alongside financial support.
Augmentum Fintech
Augmentum Fintech is the UK's only publicly listed investment company focused on the fintech sector in the UK and wider Europe, investing in fast-growing fintech businesses that are disrupting financial services.
What's next for Artificial Labs?
With the recent major strategic investment, Artificial Labs is poised for accelerated growth and further platform development. The substantial capital raised, indicated by $55.3M, suggests a strategic focus on scaling operations, expanding market reach, and potentially enhancing its AI capabilities. This funding round, classified as enterprise-level, signals confidence from investors in Artificial Labs' ability to capture a significant share of the specialty insurance technology market and solidify its position as a leader in digital transformation for the sector.
See full Artificial Labs company page
